Glucuronide: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
Glucuronide | == Glucuronide == | ||
[[File:Morphine_6-glucuronide.png|thumb|right|Chemical structure of Morphine-6-glucuronide]] | |||
A '''glucuronide''' is a compound that results from the combination of [[glucuronic acid]] with another substance via a [[glycosidic bond]]. This process is known as [[glucuronidation]], a major phase II [[metabolic pathway]] in the body. Glucuronides are important for the detoxification and excretion of various endogenous and exogenous compounds. | |||
== | == Formation == | ||
== | Glucuronides are formed in the [[liver]] by the enzyme [[UDP-glucuronosyltransferase]] (UGT). This enzyme catalyzes the transfer of glucuronic acid from [[uridine diphosphate glucuronic acid]] (UDPGA) to a substrate, which can be a [[drug]], [[hormone]], or [[toxin]]. The resulting glucuronide is more water-soluble than the parent compound, facilitating its excretion in [[urine]] or [[bile]]. | ||
* | |||
* | == Types of Glucuronides == | ||
There are several types of glucuronides, depending on the functional group of the substrate that is conjugated: | |||
* '''O-glucuronides''': Formed with [[hydroxyl]] groups. | |||
* '''N-glucuronides''': Formed with [[amine]] groups. | |||
* '''S-glucuronides''': Formed with [[thiol]] groups. | |||
* '''C-glucuronides''': Formed with [[carbon]] atoms. | |||
== Role in Drug Metabolism == | |||
Glucuronidation is a crucial pathway for the metabolism of many [[pharmaceutical drugs]]. It helps in the detoxification and elimination of drugs from the body. For example, [[morphine]] is metabolized to morphine-3-glucuronide and morphine-6-glucuronide, the latter being an active metabolite with potent analgesic properties. | |||
== Clinical Significance == | |||
The ability to form glucuronides can vary between individuals due to genetic differences in UGT enzymes. This can affect drug efficacy and toxicity. For instance, individuals with [[Gilbert's syndrome]] have reduced UGT1A1 activity, leading to increased levels of unconjugated [[bilirubin]]. | |||
== Related Pages == | |||
* [[Glucuronic acid]] | |||
* [[Glucuronidation]] | |||
* [[UDP-glucuronosyltransferase]] | |||
* [[Drug metabolism]] | |||
* [[Phase II metabolism]] | |||
[[Category:Biochemistry]] | [[Category:Biochemistry]] | ||
[[Category: | [[Category:Metabolism]] | ||
Latest revision as of 11:51, 15 February 2025
Glucuronide[edit]

A glucuronide is a compound that results from the combination of glucuronic acid with another substance via a glycosidic bond. This process is known as glucuronidation, a major phase II metabolic pathway in the body. Glucuronides are important for the detoxification and excretion of various endogenous and exogenous compounds.
Formation[edit]
Glucuronides are formed in the liver by the enzyme UDP-glucuronosyltransferase (UGT). This enzyme catalyzes the transfer of glucuronic acid from uridine diphosphate glucuronic acid (UDPGA) to a substrate, which can be a drug, hormone, or toxin. The resulting glucuronide is more water-soluble than the parent compound, facilitating its excretion in urine or bile.
Types of Glucuronides[edit]
There are several types of glucuronides, depending on the functional group of the substrate that is conjugated:
- O-glucuronides: Formed with hydroxyl groups.
- N-glucuronides: Formed with amine groups.
- S-glucuronides: Formed with thiol groups.
- C-glucuronides: Formed with carbon atoms.
Role in Drug Metabolism[edit]
Glucuronidation is a crucial pathway for the metabolism of many pharmaceutical drugs. It helps in the detoxification and elimination of drugs from the body. For example, morphine is metabolized to morphine-3-glucuronide and morphine-6-glucuronide, the latter being an active metabolite with potent analgesic properties.
Clinical Significance[edit]
The ability to form glucuronides can vary between individuals due to genetic differences in UGT enzymes. This can affect drug efficacy and toxicity. For instance, individuals with Gilbert's syndrome have reduced UGT1A1 activity, leading to increased levels of unconjugated bilirubin.